Tolerance to sustained activation of the cAMP/Creb pathway activity in osteoblastic cells is enabled by loss of p53
Journal article
Walia, Mannu K., Taylor, Scott, Ho, Patricia M.W., Martin, John and Walkley, Carl. (2018). Tolerance to sustained activation of the cAMP/Creb pathway activity in osteoblastic cells is enabled by loss of p53. Cell Death and Disease. 9(9), pp. 1 - 17. https://doi.org/10.1038/s41419-018-0944-8
Authors | Walia, Mannu K., Taylor, Scott, Ho, Patricia M.W., Martin, John and Walkley, Carl |
---|---|
Abstract | The loss of p53 function is a central event in the genesis of osteosarcoma (OS). How mutation of p53 enables OS development from osteoblastic lineage cells is poorly understood. We and others have reported a key role for elevated and persistent activation of the cAMP/PKA/Creb1 pathway in maintenance of OS. In view of the osteoblast lineage being the cell of origin of OS, we sought to determine how these pathways interact within the context of the normal osteoblast. Normal osteoblasts (p53 WT) rapidly underwent apoptosis in response to acute elevation of cAMP levels or activity, whereas p53-deficient osteoblasts tolerated this aberrant cAMP/Creb level and activity. Using the p53 activating small-molecule Nutlin-3a and cAMP/Creb1 activator forskolin, we addressed the question of how p53 responds to the activation of cAMP. We observed that p53 acts dominantly to protect cells from excessive cAMP accumulation. We identify a Creb1-Cbp complex that functions together with and interacts with p53. Finally, translating these results we find that a selective small-molecule inhibitor of the Creb1-Cbp interaction demonstrates selective toxicity to OS cells where this pathway is constitutively active. This highlights the cAMP/Creb axis as a potentially actionable therapeutic vulnerability in p53-deficient tumors such as OS. These results define a mechanism through which p53 protects normal osteoblasts from excessive or abnormal cAMP accumulation, which becomes fundamentally compromised in OS. |
Year | 2018 |
Journal | Cell Death and Disease |
Journal citation | 9 (9), pp. 1 - 17 |
Publisher | Nature Publishing Group |
ISSN | 2041-4889 |
Digital Object Identifier (DOI) | https://doi.org/10.1038/s41419-018-0944-8 |
Scopus EID | 2-s2.0-85052389246 |
Open access | Open access |
Page range | 1 - 17 |
Research Group | Mary MacKillop Institute for Health Research |
Publisher's version | License |
Place of publication | United Kingdom |
https://acuresearchbank.acu.edu.au/item/85y25/tolerance-to-sustained-activation-of-the-camp-creb-pathway-activity-in-osteoblastic-cells-is-enabled-by-loss-of-p53
Download files
122
total views78
total downloads1
views this month0
downloads this month